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INTRODUCTION:  The  incidence  of  port-site  metastasis  following  robotic-assisted  laparoscopic  hysterec-
tomy  is  unknown.
PRESENTATION  OF  CASE:  We  present  a case  of  a 78-year-old  female  diagnosed  with  an  incidental  grade  3
endometrial  adenocarcinoma  on  a ﬁnal  hysterectomy  specimen.  She  subsequently  underwent  a  robotic
staging  surgery  with  a gynecologic  oncologist  where  nodal  pathology  was  found to be negative;  her  ﬁnalobotic
ndometrial cancer
rade  3
ort-site metastasis
taging  surgery
stage  was  1B.  One  year  following  diagnosis,  she  developed  a recurrence  on  her abdominal  wall  at  the
former  port-sites  with  concomitant  vaginal  cuff  recurrence.
DISCUSSION: We  hypothesize  possible  modes  of  metastasis  and  present  limited  published  data  to  date
on  port  site metastasis  following  robotic  hysterectomy  for  endometrial  cancer.
CONCLUSION: This  is  the  second  reported  case  of port-site  metastasis  following  robotic  surgery  for
endometrial  cancer.
gical © 2013 Sur
. Introduction
Port-site metastasis (PSM) after laparoscopic and robotic sur-
eries for gynecologic cancers is rare, and the incidence after
aparoscopic staging remains low.1,2 One study reported a port-
ite metastasis rate of 0.4% for all laparoscopic procedures and
.33% for uterine cancers alone.1 Another large series reported a
SM risk of 1.18% for all laparoscopic cancer surgeries with a risk of
.059% for endometrial cancer.2 Robotic-assisted laparoscopic hys-
erectomy for surgical staging is now widely used by gynecologic
ncologists for the management of endometrial cancer. The cur-
ent published literature on PSM in gynecologic oncology largely
ertains to laparoscopic procedures with only one reported case of
SM from endometrial cancer after robotic hysterectomy.3 To the
est of our knowledge this is the second reported case of abdominal
all PSM following robotic staging surgery for endometrial cancer.. Presentation of case
A 78-year-old multiparous woman presented to her gynecolo-
ist with postmenopausal vaginal bleeding. Both an endometrial
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biopsy and a dilation and curettage specimen were negative for
endometrial malignancy. She subsequently underwent a total
abdominal hysterectomy and bilateral salpingo-oophorectomy by
her gynecologist. The ﬁnal hysterectomy specimen revealed a
FIGO grade 3 endometrioid endometrial adenocarcinoma measur-
ing 3.2 cm in maximum tumor diameter and a 1.4 cm out of 1.7 cm
depth of myometrial invasion. No lymphovascular space invasion
was noted. The patient was then referred to a gynecologic oncol-
ogist and subsequently underwent a robotic-assisted pelvic and
paraaortic lymphadenectomy, omentectomy, vaginal cuff biopsies,
and cystoscopy two  months following her initial operation. Intra-
operatively, care was  taken to place the lymph nodes into the
endo-catch bags without excessive manipulation or replacement
of the robotic trocars. A total of 27 lymph nodes (20 pelvic and
7 paraaortic) were sampled and were negative for malignancy. All
pelvic washings, vaginal cuff biopsies, and omental specimens were
also negative. The diagnosis was a stage IB, grade 3 endometrioid
endometrial cancer, and the patient elected to undergo adjuvant
vaginal brachytherapy.
She  remained without evidence of disease until her 12-month
follow-up when she was  incidentally found to have two  1.5 cm nod-
ules on her anterior abdominal wall in the right and left lower
quadrants, conﬁrmed by CT imaging (Fig. 1). Both nodules were
three cm inferior to the previous robotic trocar sites. Two  nod-
Open access under CC BY-NC-ND license. ules were also noted at the vaginal cuff. She underwent surgical
exploration of the abdominal wall, resection of the two abdominal
wall masses, vaginal cuff biopsies and cystoscopy. Intraoperative
ﬁndings were signiﬁcant for the abdominal wall masses imbedded
Y-NC-ND license. 
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bFig. 1. Abdominal CT (axial). Abdominal wall port site metastas
ithin the fascia on the right and both the fascia and the peri-
oneum on the left.
The  pathology of these masses revealed metastatic, poorly dif-
erentiated adenocarcinoma, FIGO grade 3, consistent with the
ndometrial primary. The largest mass diameter measured 2.9 cm.
ll vaginal cuff biopsies were also consistent with adenocarcinoma.
Postoperatively, the patient received six cycles of chemother-
py with IV carboplatin and paclitaxel and had a robust response
ith no evidence of clinically measurable disease. She is currently
isease free one year after treatment.
. Discussion
Port-site metastasis (PSM) following robotic surgery for early-
tage endometrial cancer is exceedingly rare. To the best of our
nowledge, this is the second case of port-site metastasis after
obotically staged endometrial cancer to be reported in the liter-
ture. Interestingly, the recurrent abdominal wall nodules in this
atient were located 3 cm below the previous trochar sites bilat-
rally but away from the patient’s prior Pfannenstiel scar. We
ypothesize that this was likely do to the angulation of the robotic
rocars toward the pelvis during surgery.
Despite negative nodal pathology, the patient’s cancer recurred
t the previous trocar sites. As mentioned, care was  taken to min-
mize manipulation of trocars, which were also removed prior to
omplete deﬂation of the abdomen. Given the patient’s negative
ymph nodes, pelvic washings, and omentectomy, it is unusual that
he patient’s recurrence would present as tumor nodules at the
obotic port-sites. Although we cannot explain these ﬁndings, we
ypothesize a few considerations. Positive pelvic and/or paraaortic
ymph nodes not sampled by the surgeon may  have disseminated
ematogenously to the site of recent trauma, i.e. the port sites. Pen-
tration of tissue planes during staging surgery upon entry of the
eritoneum with trocars as well as entry into the retroperitoneum
ith robotic instrumentation may  have allowed direct spread of
atent tumor cells to implant at these sites. Although this would
ot explain metastatic tumor nodules at the vaginal cuff, colpo-
omy at the time of the patient’s primary surgery may  have resulted
n direct spread of tumor cells that manifested grossly with time,
oincidentally with the abdominal tumor recurrences.
The incidence of port site metastasis in endometrial cancer is
ikely to grow with increasing use of robotic staging surgery. Only
ne other case, by Ndofor et al., has been reported on abdominal
SM following robotic hysterectomy in endometrial cancer.3 One
atient, out of 116 who underwent RA-TLH for uterine cancer, had a
ort site recurrence at the umbilical trocar site with concommitant
etroperitoneal lymphadenopathy and peritoneal carcinomatosis.3
he risk of developing PSM in this series was 1.1% for all gynecologic
ancers and 0.055% for uterine cancer.3 These rates are similar to
hose for laparoscopic surgeries performed for gynecologic malig-
ancies (0.4–1.18%).1,2 Although four cases of isolated PSM can
e found in the laparoscopic literature, isolated PSM, withoutt sided nodule (left image) and left-sided nodule (right image).
metastasis  to other sites, in robotically staged endometrial cancer
patients have not been published.4
In another series on PSM following laparoscopic-assisted vagi-
nal hysterectomy (LAVH), one out of 547 patients with uterine
cancer had PSM.2 This same series found that all gynecologic can-
cer patients who developed PSM within seven months of surgery
had a median survival of 12 months, while those who devel-
oped PSM at an interval greater than seven months had 37 month
median survival (P = .004).2 It has been reported that an aggressive
histologic grade is more commonly associated with non-isolated
or concomitant PSM as afﬁrmed in this case.4 It appears that
laparoscopy-related port-site metastases are uncommon and seem
to predominantly occur in the setting of advanced disease.4
4. Conclusion
Due to the limited number of cases of PSM following robotic
surgery for endometrial cancer we  believe that the rates of simul-
taneous carcinomatosis as well as survival data for LAVH PSM can
be extrapolated to robotic cases for gynecologic malignancies when
counseling patients on prognosis.
As more robotic procedures are performed worldwide, for both
endometrial and other gynecologic cancers, similar cases will need
to be published before uniform prevention strategies can be pro-
posed.
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